Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Lundbeck doubled its offer for Longboard over six months, new filing shows
6 months ago
Deals
Blue Earth Therapeutics snags $76M for both alpha and beta radiotherapies
6 months ago
Financing
Startups
Biogen signs molecular glue deal, raises yearly projections
6 months ago
Deals
R&D
Updated: Lilly’s shares tank after trimming revenue guidance. It also cut three assets
6 months ago
Pharma
A startup backed by Nobel winner David Baker takes an AI twist on antibodies
6 months ago
Financing
Startups
GSK remains ‘very confident’ in RSV vaccine amid competition, sales slump
6 months ago
Pharma
Axonis snags $115M to test oral drugs for epilepsy and neuropathic pain
6 months ago
Financing
Startups
Sage, Biogen won't pursue major depression approval for postpartum pill
6 months ago
R&D
Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’
6 months ago
R&D
Pharma
Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA
6 months ago
FDA+
Manufacturing
Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins
6 months ago
Pharma
FDA+
Lexicon's once-rejected diabetes drug is questioned again by FDA ahead of adcomm
6 months ago
Pharma
FDA+
Coya shares sink on Phase 2 Alzheimer's data for deprioritized drug
6 months ago
R&D
Novartis expands Scemblix label to first-line CML patients
6 months ago
Pharma
FDA+
Shionogi touts topline data for Covid-19 antiviral for post-exposure treatment
6 months ago
R&D
Pharma
MilliporeSigma invests €70M to triple ADC manufacturing at US site
6 months ago
Manufacturing
PacBio bets on 'inflection point' with $500 long-read genome
6 months ago
R&D
Diagnostics
Novartis highlights overall M&A track record following MorphoSys impairment
6 months ago
Deals
Pharma
In bid to lower ARIA-E, Eli Lilly tries a different dosing regimen for its Alzheimer's drug
6 months ago
R&D
Pharma
Vera’s $300M offering; Abeona resubmits treatment for rare skin disease
6 months ago
News Briefing
Two type 1 diabetes patients are insulin-free after Eledon's immunosuppressant and an islet transplant
6 months ago
R&D
GSK buys autoimmune T cell engager for $300M upfront from Chimagen
6 months ago
Deals
Eyepoint sells $100M in shares after unveiling eye disease data for drug-device asset
6 months ago
R&D
#HLTH24: GLP-1 compounding pharmacies took center stage at digital health’s biggest conference
6 months ago
Pharma
FDA+
First page
Previous page
72
73
74
75
76
77
78
Next page
Last page